REPROGRAM-01, a phase II study of regorafenib in combination with a multimodal metronomic chemotherapy in patients with metastatic colorectal cancer

Affiliation auteurs!!!! Error affiliation !!!!
TitreREPROGRAM-01, a phase II study of regorafenib in combination with a multimodal metronomic chemotherapy in patients with metastatic colorectal cancer
Type de publicationJournal Article
Year of Publication2021
AuteursKlajer E., Jary M., Borg C., Kim S., Vernerey D., Henriques J., N'Guyen T., Nasri M., Almotlak H., Babre J., Meurisse A., Fratte S., Fein F., Calcagno F., Chanut L., Spehner L., Rebucci-Peixoto M., Vienot A.
JournalANNALS OF ONCOLOGY
Volume32
PaginationS581
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2021.08.1028